pharmaceuticals

GlaxoSmithKline Seeks No Patent to Make Medicines More Affordable for Poor Nations

GlaxoSmithKline pledged not to file patents to make drugs more affordable to poor countries. Any GSK drugs that are included in the list of the World Health Organization's important medicines will be included automatically.

Read Full Article

Fund managers boost bets on health care even amid high prices

Last July, when Federal Reserve Chair Janet Yellen spurred a sell-off in healthcare stocks by saying that valuations in shares of biotech companies looked "stretched," portfolio manager Graham Tanaka saw an opportunity.

Read Full Article

Roche to buy U.S. biotech firm InterMune for $8.3 billion

Roche Holding AG has agreed to buy U.S. biotech company InterMune Inc for $8.3 billion in cash, marking the latest multibillion-dollar deal in a consolidating pharmaceutical sector.

Read Full Article

McKesson obtains bridge loan

The approval for a bridge loan was given to McKesson to facilitate its acquisition of Celesio AG.

Read Full Article

AstraZeneca, Novartis, Pfizer prepare bids for Onyx Pharmaceuticals

Pharmaceutical giants Pfizer, AstraZeneca and Novartis are among those to propose bids for Onyx Pharmaceuticals.

Read Full Article

Ipsen acquires Syntaxin

Ipsen announced the acquisition of UK-based private life sciences company, Syntaxin.

Read Full Article

New jobs open in Ireland as Pfizer invests

Pfizer invests in two plants in Ireland.

Read Full Article

Chilean Pharmaceutical Company Plans to Expand Big in South Africa

CFR Pharmaceuticals has embarked on a South African road show starting June 08.

Read Full Article

India Cipla to Take Over South Africa Cipla

Cipla Ltd offers to take over Cipla Medpro South Africa.

Read Full Article

Royal Pharma Proposes $11 Per Share to Elan for Tysabri Royalty Rights

Royalty Pharma has been making big approaches to acquire the royalty rights for Tysabri from the Irish drug maker.

Read Full Article

Progenics buys Molecular Insight Pharmaceuticals

Progenics Pharmaceuticals today announced that it has acquired Molecular Insight Pharmaceuticals

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics